368 related articles for article (PubMed ID: 27835934)
21. Structural basis for functional tetramerization of lentiviral integrase.
Hare S; Di Nunzio F; Labeja A; Wang J; Engelman A; Cherepanov P
PLoS Pathog; 2009 Jul; 5(7):e1000515. PubMed ID: 19609359
[TBL] [Abstract][Full Text] [Related]
22. Biophysical investigation of type A PutAs reveals a conserved core oligomeric structure.
Korasick DA; Singh H; Pemberton TA; Luo M; Dhatwalia R; Tanner JJ
FEBS J; 2017 Sep; 284(18):3029-3049. PubMed ID: 28710792
[TBL] [Abstract][Full Text] [Related]
23. Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase.
Andrake MD; Skalka AM
J Biol Chem; 1995 Dec; 270(49):29299-306. PubMed ID: 7493962
[TBL] [Abstract][Full Text] [Related]
24. The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical.
Galilee M; Britan-Rosich E; Griner SL; Uysal S; Baumgärtel V; Lamb DC; Kossiakoff AA; Kotler M; Stroud RM; Marx A; Alian A
Structure; 2016 Nov; 24(11):1936-1946. PubMed ID: 27692964
[TBL] [Abstract][Full Text] [Related]
25. High-resolution structure of the catalytic domain of avian sarcoma virus integrase.
Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM
J Mol Biol; 1995 Oct; 253(2):333-46. PubMed ID: 7563093
[TBL] [Abstract][Full Text] [Related]
26. Computer aided study of ligand binding with catalytic domain of Avian sarcoma virus integrase and its ligand binding loops.
Kumar A; Shankar S; Kothekar V
J Biomol Struct Dyn; 2001 Dec; 19(3):449-58. PubMed ID: 11790143
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics studies on the HIV-1 integrase catalytic domain.
Lins RD; Briggs JM; Straatsma TP; Carlson HA; Greenwald J; Choe S; McCammon JA
Biophys J; 1999 Jun; 76(6):2999-3011. PubMed ID: 10354426
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 integrase: structural organization, conformational changes, and catalysis.
Asante-Appiah E; Skalka AM
Adv Virus Res; 1999; 52():351-69. PubMed ID: 10384242
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the Rous sarcoma virus intasome.
Yin Z; Shi K; Banerjee S; Pandey KK; Bera S; Grandgenett DP; Aihara H
Nature; 2016 Feb; 530(7590):362-6. PubMed ID: 26887497
[TBL] [Abstract][Full Text] [Related]
30. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.
Lubkowski J; Yang F; Alexandratos J; Wlodawer A; Zhao H; Burke TR; Neamati N; Pommier Y; Merkel G; Skalka AM
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4831-6. PubMed ID: 9560188
[TBL] [Abstract][Full Text] [Related]
31. Structural insight into GRIP1-PDZ6 in Alzheimer's disease: study from protein expression data to molecular dynamics simulations.
Chatterjee P; Roy D
J Biomol Struct Dyn; 2017 Aug; 35(10):2235-2247. PubMed ID: 27425598
[TBL] [Abstract][Full Text] [Related]
32. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a naphthalene derivative inhibitor of retroviral integrases.
Daniel R; Myers CB; Kulkosky J; Taganov K; Greger JG; Merkel G; Weber IT; Harrison RW; Skalka AM
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):135-44. PubMed ID: 15018700
[TBL] [Abstract][Full Text] [Related]
34. Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.
Lee MC; Deng J; Briggs JM; Duan Y
Biophys J; 2005 May; 88(5):3133-46. PubMed ID: 15731379
[TBL] [Abstract][Full Text] [Related]
35. Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied.
Ercan S; Pirinccioglu N
J Mol Model; 2013 Oct; 19(10):4349-68. PubMed ID: 23907552
[TBL] [Abstract][Full Text] [Related]
36. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
Sippel M; Sotriffer CA
J Chem Inf Model; 2010 Apr; 50(4):604-14. PubMed ID: 20230013
[TBL] [Abstract][Full Text] [Related]
37. Solution conformation and dynamics of the HIV-1 integrase core domain.
Fitzkee NC; Masse JE; Shen Y; Davies DR; Bax A
J Biol Chem; 2010 Jun; 285(23):18072-84. PubMed ID: 20363759
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination of non-lysine residues in the retroviral integrase.
Wang Z; Hou X; Wang Y; Xu A; Cao W; Liao M; Zhang R; Tang J
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):57-62. PubMed ID: 29054407
[TBL] [Abstract][Full Text] [Related]
39. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc.
Eijkelenboom AP; van den Ent FM; Vos A; Doreleijers JF; Hård K; Tullius TD; Plasterk RH; Kaptein R; Boelens R
Curr Biol; 1997 Oct; 7(10):739-46. PubMed ID: 9368756
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of the integrase-DNA complex by Mg2+ ions and prediction of key residues for binding HIV-1 integrase inhibitors.
Miri L; Bouvier G; Kettani A; Mikou A; Wakrim L; Nilges M; Malliavin TE
Proteins; 2014 Mar; 82(3):466-78. PubMed ID: 24038133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
